Advertisement

Topics

Patients Getting Faster Access to Cancer Drugs as NICE Approves Three Quarters of Cancer Drug Fund

15:00 EDT 18 Aug 2017 | Drug Discovery Development

Liver cancer drug, sorafenib has been approved for routine NHS use, marking three quarters of the way through the Cancer Drugs Fund (CDF) without a negative decision.
Contributed Author: 
NICE
Topics: 

Original Article: Patients Getting Faster Access to Cancer Drugs as NICE Approves Three Quarters of Cancer Drug Fund

NEXT ARTICLE

More From BioPortfolio on "Patients Getting Faster Access to Cancer Drugs as NICE Approves Three Quarters of Cancer Drug Fund"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...